These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 30212434)
1. Is on-Demand HIV Pre-exposure Prophylaxis a Suitable Tool for Men Who Have Sex With Men Who Practice Chemsex? Results From a Substudy of the ANRS-IPERGAY Trial. Roux P; Fressard L; Suzan-Monti M; Chas J; Sagaon-Teyssier L; Capitant C; Meyer L; Tremblay C; Rojas-Castro D; Pialoux G; Molina JM; Spire B J Acquir Immune Defic Syndr; 2018 Oct; 79(2):e69-e75. PubMed ID: 30212434 [TBL] [Abstract][Full Text] [Related]
2. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Antoni G; Tremblay C; Delaugerre C; Charreau I; Cua E; Rojas Castro D; Raffi F; Chas J; Huleux T; Spire B; Capitant C; Cotte L; Meyer L; Molina JM; Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343 [TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L; Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274 [TBL] [Abstract][Full Text] [Related]
4. Changes in Sexual Behaviors in Men Who Have Sex with Men: A Comparison Between the Double-Blind and Open-Label Extension Phases of the ANRS-IPERGAY Trial. Di Ciaccio M; Sagaon-Teyssier L; Mimi M; Suzan-Monti M; Protiere C; Rojas Castro D; Meyer L; Tremblay C; Chidiac C; Capitant C; Préau M; Molina JM; Spire B; AIDS Behav; 2020 Nov; 24(11):3093-3106. PubMed ID: 32306213 [TBL] [Abstract][Full Text] [Related]
5. Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants. O'Halloran C; Rice B; White E; Desai M; Dunn DT; McCormack S; Sullivan AK; White D; McOwan A; Gafos M Int J Drug Policy; 2019 Dec; 74():246-254. PubMed ID: 31739177 [TBL] [Abstract][Full Text] [Related]
6. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial. Sagaon-Teyssier L; Suzan-Monti M; Demoulin B; Capitant C; Lorente N; Préau M; Mora M; Rojas Castro D; Chidiac C; Chas J; Meyer L; Molina JM; Spire B; AIDS Care; 2016; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400 [TBL] [Abstract][Full Text] [Related]
7. Pre-exposure prophylaxis (PrEP) uptake and adherence experiences of gay and bisexual men who engage in chemsex: A qualitative study. Maxwell S; Shahmanesh M; Gafos M Int J Drug Policy; 2022 May; 103():103630. PubMed ID: 35231668 [TBL] [Abstract][Full Text] [Related]
8. Chemsex practices and pre-exposure prophylaxis (PrEP) trajectories among individuals consulting for PrEP at a large sexual health clinic in Montréal, Canada (2013-2020). Flores Anato JL; Panagiotoglou D; Greenwald ZR; Trottier C; Vaziri M; Thomas R; Maheu-Giroux M Drug Alcohol Depend; 2021 Sep; 226():108875. PubMed ID: 34218004 [TBL] [Abstract][Full Text] [Related]
9. Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective study. Hammond R; Cambiano V; Lampe FC; Asboe D; Clarke A; Gilson R; Hart GJ; Miltz AR; Nwokolo N; Johnson AM; Phillips AN; Speakman A; Whitlock G; Rodger A; Sewell J Sex Transm Infect; 2023 Nov; 99(7):474-481. PubMed ID: 37321843 [TBL] [Abstract][Full Text] [Related]
10. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. Hanum N; Cambiano V; Sewell J; Phillips AN; Rodger AJ; Speakman A; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Lampe FC; Lancet Public Health; 2020 Sep; 5(9):e501-e511. PubMed ID: 32888443 [TBL] [Abstract][Full Text] [Related]
11. Coverage of Sex Acts by Event-Driven Pre-exposure Prophylaxis: A Sub-Study of the ANRS IPERGAY Trial. Bauer R; Netzer E; Pintado C; Capitant C; Cua E; Etien N; Fonsart J; Pialoux G; Chidiac C; Etienne C; Doré V; Meyer L; Molina JM; AIDS Behav; 2020 Nov; 24(11):3244-3251. PubMed ID: 32350771 [TBL] [Abstract][Full Text] [Related]
12. The ANRS-Ipergay trial, an opportunity to use qualitative research to understand the perception of the "participant"-physician relationship. Di Ciaccio M; Protiere C; Rojas Castro D; Suzan-Monti M; Chas J; Cotte L; Siguier M; Cua E; Spire B; Molina JM; Preau M; AIDS Care; 2018 Jun; 30(sup2):41-47. PubMed ID: 29848004 [TBL] [Abstract][Full Text] [Related]
13. Can We Predict Incorrect PrEP Use in High HIV Risk Situations Among Men Who Have Sex With Men? An Analysis of Be-PrEP-ared, the Belgian PrEP Demonstration Study. Vuylsteke B; Reyniers T; Nöstlinger C; Smekens T; Kenyon C; Laga M J Acquir Immune Defic Syndr; 2021 Sep; 88(1):36-44. PubMed ID: 34081665 [TBL] [Abstract][Full Text] [Related]
14. Uptake and willingness to use PrEP among Chinese gay, bisexual and other men who have sex with men with experience of sexualized drug use in the past year. Wang Z; Mo PKH; Ip M; Fang Y; Lau JTF BMC Infect Dis; 2020 Apr; 20(1):299. PubMed ID: 32321442 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with partner notification of STIs in men who have sex with men on PrEP in France: a cross-sectional substudy of the ANRS-IPERGAY trial. Suzan-Monti M; Cotte L; Fressard L; Cua E; Capitant C; Meyer L; Pialoux G; Molina JM; Spire B; Sex Transm Infect; 2018 Nov; 94(7):490-493. PubMed ID: 29378903 [TBL] [Abstract][Full Text] [Related]
16. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP). Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439 [TBL] [Abstract][Full Text] [Related]
17. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France). Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B; Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial. Chas J; Bauer R; Larabi IA; Peytavin G; Roux P; Cua E; Cotte L; Pasquet A; Capitant C; Meyer L; Raffi F; Spire B; Pialoux G; Molina JM; Alvarez JC J Acquir Immune Defic Syndr; 2021 Apr; 86(5):552-561. PubMed ID: 33394814 [TBL] [Abstract][Full Text] [Related]
19. Do pre-exposure prophylaxis (PrEP) users engaging in chemsex experience their participation as problematic and how can they best be supported? Findings from an online survey in Belgium. Vanbaelen T; Rotsaert A; Van Landeghem E; Nöstlinger C; Vuylsteke B; Platteau T; Herrijgers C; Reyniers T Sex Health; 2023 Oct; 20(5):424-430. PubMed ID: 37487323 [TBL] [Abstract][Full Text] [Related]
20. Impact of COVID-19 Pandemic on Men Who Have Sex With Men That Practice Chemsex in France: Results From the National ERAS Web Survey. Roux P; Donadille C; Girard G; Spire B; Protière C; Velter A Am J Mens Health; 2022; 16(1):15579883211073225. PubMed ID: 35156425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]